RecruitingNot ApplicableNCT07031986

Bronchial Blockers vs Double-Lumen Tubes in Obese Patients

One-lung Ventilation With Double-Lumen Tubes and Bronchial Blockers in Obese Patients Undergoing Lung Resection


Sponsor

Paulo Andrés Cano Jiménez

Enrollment

46 participants

Start Date

Aug 15, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this clinical trial is to evaluate the efficacy of bronchial blockers and double-lumen tubes in achieving one-lung ventilation in obese patients undergoing lung resections. The primary question it aims to answer is: • Is intraoperative hypoxia significantly different depending on the device used? Researchers will compare the use of bronchial blockers and double-lumen tubes to assess differences in efficacy and safety. Participants will not be required to perform any tasks.


Eligibility

Min Age: 18 YearsMax Age: 90 Years

Inclusion Criteria4

  • BMI ≥ 30 kg/m2
  • Diagnostic or clinical suspicion of lung cancer
  • Lung resection surgery (lobectomy, segmentectomy or wedge resection) by VATS or thoracotomy, requiring one-lung ventilation.
  • Use of bronchial blocker or double-lumen tube for one-lung ventilation.

Exclusion Criteria2

  • Patients with evident anatomic alterations, in which double-lumen tubes may be contraindicated.
  • Emergency surgeries.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEOne-Lung ventilation with Double-Lumen Tube

To achieve the required one-lung ventilation during lung resection, patients will be managed with a double-lumen tube.

DEVICEOne-Lung Ventilation with Bronchial Blocker

To achieve the required one-lung ventilation during lung resection, patients will be managed with a bronchial blocker.


Locations(1)

Hospital Son Espases

Palma de Mallorca, Balearic Islands, Spain

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07031986


Related Trials